Home - CIMIT MAIN
News and Events
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
Test Enables Single-Visit Testing and Treatment for Hepatitis C
Read More
»
Connect with Us
Our Lasting Impact
As an early pioneer in managing translational research, Cimit has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.
We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.
We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.